Rigel Pharmaceuticals (RI2.STU) Q3 2026 Earnings

4AugConfirmed
Q2 2026
Next
0.18
0.34
0.51
0.68

Details

Expected EPS
0.177217222
Actual EPS
N/A
Surprise EPS
-0.18
Surprise Percent
+100%

Description

Rigel Pharmaceuticals (RI2.STU) will report earnings of for Q3 2026 on August 04, 2026.

0 Comments

Share your thoughts